Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Goyang-si Gyeonggi-do
Clinical trial register · South Korea

Clinical Trials in Goyang-si Gyeonggi-do, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3409 matching records held by the registry are in this view. Synced 17 Nov 2026, 03:18 UTC
3409
Studies in scope
all four open statuses
1874
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Seoul 2866 Daegu 553 Seongnam-si 485 Busan 470 Goyang-si 399
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Goyang-si Gyeonggi-do

15 of 3409 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Active, closed
Amgen
Phase 3
350
Cheongju Chungbuk, Goyang-si Gyeonggi-do, Seoul
2025-08-18
Active, closed
Amgen
Phase 3
12,800
Daegu, Goyang-si, Gyeonggi-do, Incheon, Seongnam-si, Gyeonggi-do, Seoul, Ulsan, Wonju-si, Gangwon-do
2025-07-25
Active, closed
Amgen
Phase 3
3,853
Ansan-si, Gyeonggi-do, Anyang-si, Gyeonggi-do, Bucheon, Gyeonggi-do, Busan, Daegu, Daejeon, Goyang-si, Gyeonggi-do, Incheon
2025-03-12
Active, closed
Amgen
Phase 3
707
Daejeon, Goyang-si, Gyeonggi-do, Seongnam-si, Gyeonggi-do, Seoul
2024-12-09
Active, closed
Amgen
Phase 3
563
Cheongju Chungbuk, Goyang-si Gyeonggi-do, Seongnam-si, Gyeonggi-do, Seoul
2024-06-05
Recruiting
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
NCT06400472Ovarian Neoplasms, Endometrial Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company
Phase 1
575
Goyang-si Gyeonggi-do
2024-05-20
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
Amgen
Phase 3
404
Cheongju Chungbuk, Goyang-si Gyeonggi-do, Incheon, Jinju, Seongnam-si, Gyeonggi-do, Seoul
2024-02-20
Recruiting
Gilead Sciences
Phase 1
278
Gangnam-Gu, Goyang-si Gyeonggi-do, Seoul
2024-01-09
Active, closed
Amgen
Phase 3
509
Cheongju Chungbuk, Goyang-si Gyeonggi-do, Incheon, Jinju, Seongnam-si, Gyeonggi-do, Seoul, Ulsan
2023-05-31
Active, closed
Gilead Sciences
Phase 3
654
Gangnam-Gu, Goyang-si Gyeonggi-do, Gyeongsangbuk-do, Incheon, Seongnam, Seoul
2023-05-08
Active, closed
Gilead Sciences
Phase 3
623
Goyang-si Gyeonggi-do, Seongnam-si, Seoul
2022-07-20
Active, closed
A Phase 2 Study of Tarlatamab in Patients With Small Cell Lung Cancer (SCLC)
NCT05060016Relapsed/Refractory Small Cell Lung Cancer
Amgen
Phase 2
222
Goyang-si Gyeonggi-do, Seongnam-si, Gyeonggi-do, Seoul
2021-12-01
Rows per page Showing 1–15 of 15
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 19 November 2026. https://priyalifescience.com/clinical-trials-south-korea/city/goyang-si-gyeonggi-do

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,409 studies in total at the last sync on 17 Nov 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 15 of those studies with a site in Goyang-si Gyeonggi-do.

How many clinical trials are recruiting in Goyang-si Gyeonggi-do?

4 of the 15 studies on this page are recruiting new participants as of the 17 Nov 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 11 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Goyang-si Gyeonggi-do), 15 studies
PhaseStudiesRecruitingShare
Phase 312280%
Phase 12213.3%
Phase 2106.7%

Most active sponsors

Lead sponsors with the most studies (Goyang-si Gyeonggi-do)
Lead sponsorStudiesRecruiting
Amgen102
Gilead Sciences41
Eli Lilly and Company11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.